UPDATE: Baird Upgrades IQVIA Holdings (IQV) to Outperform

(updated to add analyst comment)

Baird upgraded IQVIA Holdings (NYSE: IQV) from Neutral to Outperform with a price target of $127.00 (from $109.00).

Analyst Eric Coldwell comments "Another deep dive with management and we are bought in. Always expected the first 2-3 years of IMS+Q to bring ample controversy; we had time to see how it would build novel clinical, commercial, consulting and real-world solutions. We like what we see: very cool stuff. It doesn’t hurt that the shares underperformed most peers YTD and TTM so relative and absolute valuation are too disjointed to ignore. We expect strong one-year returns, but consider IQV a long-term core holding."

For an analyst ratings summary and ratings history on IQVIA Holdings click here. For more ratings news on IQVIA Holdings click here.

Shares of IQVIA Holdings closed at $103.28 yesterday.

You May Also Be Interested In

• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• DA Davidson Starts Comfort Systems USA (FIX) at Buy